Scottish HTA body OKs Lynparza For Earlier Use In Ovarian Cancer
Move Follows NICE Recommendation For England In July
Executive Summary
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.